Iterum Therapeutics PLC
NASDAQ:ITRM
Iterum Therapeutics PLC
NASDAQ:ITRM
Price:
1.61 USD
0.63%
Market Closed
Updated:
May 10, 2024
Iterum Therapeutics PLC
EPS (Diluted)
|
Iterum Therapeutics PLC
EPS (Diluted) Peer Comparison
Comparables:
PRGO
JAZZ
AVDL
G
GHRS
COPN
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Iterum Therapeutics PLC
NASDAQ:ITRM
|
EPS (Diluted)
-$2
|
CAGR 3-Years
55%
|
CAGR 5-Years
48%
|
CAGR 10-Years
N/A
|
|
|
Perrigo Company PLC
NYSE:PRGO
|
EPS (Diluted)
$0
|
CAGR 3-Years
58%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
|
EPS (Diluted)
$5
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
14%
|
|
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
EPS (Diluted)
-$2
|
CAGR 3-Years
N/A
|
CAGR 5-Years
5%
|
CAGR 10-Years
-2%
|
|
G
|
GH Research PLC
NASDAQ:GHRS
|
EPS (Diluted)
$0
|
CAGR 3-Years
-308%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cosmo Pharmaceuticals NV
SIX:COPN
|
EPS (Diluted)
€0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-34%
|
See Also
What is Iterum Therapeutics PLC's EPS (Diluted)?
EPS (Diluted)
-3
USD
-3
USD
Based on the financial report for Dec 31, 2023, Iterum Therapeutics PLC's EPS (Diluted) amounts to -3 USD.
What is Iterum Therapeutics PLC's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
48%
48%
Over the last year, the EPS (Diluted) growth was 18%. The average annual EPS (Diluted) growth rates for Iterum Therapeutics PLC have been 55% over the past three years , 48% over the past five years .
You don't have any saved screeners yet
